Author:
Goonewardene Sanchia S.,Ventii Karen,Bahl Amit,Persad Raj,Motiwala Hanif,Albala David
Publisher
Springer International Publishing
Reference29 articles.
1. Tsao CK, Liaw BC, Oh WK, Galsky MD. Muscle invasive bladder cancer: closing the gap between practice and evidence. Minerva Urol Nefrol. 2015;67(1):65–73.
2. King K, Steggall M. Haematuria: from identification to treatment. Br J Nurs. 2014;23(9):S28–32.
3. Ramirez D, Gupta A, Canter D, Harrow B, Dobbs RW, Kucherov V, Mueller E, Streeper N, Uhlman MA, Svatek RS, Messing EM, Lotan Y. Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer. BJU Int. 2016;117(5):783–6.
4. Cha EK, Tirsar LA, Schwentner C, Hennenlotter J, Christos PJ, Stenzl A, Mian C, Martini T, Pycha A, Shariat SF, Schmitz-Dräger BJ. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World J Urol. 2012;30(6):847–52.
5. Ordell Sundelin M, Jensen JB. Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract. Scand J Urol. 2017;51(5):373–5.